RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Cervical Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 66 pages - $1,000
Cervical Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 49 pages - $2,000
Cervical Cancer Therapy Area Pipeline Report
Nov 2010 - 146 pages - $1,495
S-1 (Cervical Cancer) – Analysis and Forecasts to 2020
Oct 2011 - 23 pages - $2,000
Stakeholder Opinions: Cervical and Endometrial Cancer - Opportunities remain outside the big gynecologic malignancies
Mar 2010 - 101 pages - $3,800
Tirazone (Cervical Cancer) – Analysis and Forecasts to 2020
Oct 2011 - 22 pages - $2,000
Epidemiology: Cervical Cancer - The small decrease in cervical cancer cases over the next decade in the seven major markets is driven by decreasing incidence rates
Feb 2011 - 33 pages - $5,700
Avastin (Cervical Cancer) – Analysis and Forecasts to 2020
Oct 2011 - 22 pages - $2,000
V503 (Cervical Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 28 pages - $2,000
Gardasil (Cervical Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 28 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Topical del
Dermatological del
Therapeutic target
Oncology del
Cervical cancer del
Adenocarcinoma del

Browse By

Industry sector
Aerosol
Collodion/Lacquer
Dressing
Emulsion
Foam
Gel
Liquid
Ointment
Other
Spray
Suspension
Wash/Soap
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us